The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
about
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcomaMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersTargeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signalingMechanisms of evasive resistance to anti-VEGF therapy in glioblastomaRegistered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironmentFour individually druggable MET hotspots mediate HGF-driven tumor progression.Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.The evolving landscape of glioblastoma stem cells.Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma.Role of receptor tyrosine kinases and their ligands in glioblastoma.DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification.Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.Glial progenitors as targets for transformation in glioma.Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach.Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells.Canonical genetic signatures of the adult human brain.Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.Biological and clinical implications of cancer stem cells in primary brain tumors.In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like CellsIonizing radiation in glioblastoma initiating cells.Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.JNK Signaling in the Control of the Tumor-Initiating Capacity Associated with Cancer Stem Cells.MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Dynamic Interactions Between Cancer Stem Cells And Their Stromal Partners.MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells.Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma.Signals that regulate the oncogenic fate of neural stem cells and progenitorsEpidermal growth factor receptor as a therapeutic target in glioblastoma.EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.Targeting the oncogenic Met receptor by antibodies and gene therapy.Molecular heterogeneity of glioblastoma and its clinical relevance.Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target.Hepatocyte growth factor and Met in drug discovery.Promise and challenges on the horizon of MET-targeted cancer therapeuticsImmunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies.Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.
P2860
Q21245750-0713578E-9F38-4E21-9B4D-5B94BB7A13B6Q26822406-F4DE7C5F-B4FB-4614-A947-FE065A095D68Q27011423-8B9E79DF-ECFA-4D77-B7C4-502EDD2B123DQ27021470-89FF8ABE-E398-4BA5-B639-BC876B20AA6BQ28610515-C6137E48-D975-4814-88D8-6603EEB5E514Q30581656-50C61D65-D937-44A8-9D5E-E84316B9CFF5Q33643498-DA246090-8E69-445E-87F9-49C4FAF4E8F2Q33652614-14D248FA-D986-4D69-8316-5D6F2A351E01Q33753468-D6FB70F1-FC86-4315-A514-1F78DC6FCBA0Q33883849-93338310-A04B-44CE-92B1-8D6EAC8240BFQ34203095-33714A71-CAD8-4046-B0EC-CB9B2A56FB76Q34494731-7BA046B4-7753-4CA0-990D-5847EFEB52B5Q34735661-E837E24F-C447-4A68-A9DD-2FA494493D2CQ34783220-ED3101F7-39E6-45C7-B9EB-1BCB8041DC11Q36275660-7AEEB193-1A3C-4A68-ABB4-B88021CDE274Q36288237-74190467-7276-485C-BBA8-75A06FFBDA52Q36428141-3FB03134-DDA5-42E1-A6C0-F4366000D924Q36544112-2AA0DACE-6172-4139-9689-73CC460E1ACEQ36562573-00B527E1-27F9-4D0A-9054-D2BA4865C9C4Q36730368-601462A6-E5A7-4750-B4E4-5A7EEF39D7E8Q36746959-A37EC96D-81FA-48A9-AA54-4D02A516E9B5Q37071045-03D2F7F8-0A93-4B97-82FD-1B093AD9021DQ37329811-DD4543CA-1477-4AC8-BBBC-A797157F5CCCQ37392537-60273A0F-D52E-48DF-B47E-AF6145300242Q37458626-3FA020B5-FE78-41D0-AB00-186162AE8D5CQ37544362-A2D44F21-C34C-4406-B047-D9C61E58DA5AQ37610799-E813617D-40E7-47FF-BE86-4F382C5BE2ADQ37641700-C8C5530B-8B4E-4415-8EB0-10296A897BB3Q37666955-0F0C9834-904A-4441-BFFF-A9F8E5BD6356Q37688612-FBFC2A9B-7E11-4849-8CE9-08227C39910CQ38078705-111556A6-DD15-4D8F-A040-596B515BB3BEQ38098098-B08CD0D2-37D0-4FAF-890B-28C2F224A61EQ38199643-879F3FA6-594C-49AB-8EE3-A1DF78FB854EQ38216590-6EEC9B9C-D0D8-47E1-8711-A1B0B368AA08Q38243193-027E9F47-6D5E-4307-AAAD-D158E149384DQ38287518-9D620038-B5CD-4212-AD38-46A14756DC17Q38377273-FD15A00A-960A-4F49-9376-BCE2C888E578Q38502350-28453ED0-BAE7-466D-AB31-7B6B988B24A8Q38588141-70F15351-0CCB-4F21-9BAF-82DCD9F24511Q38829440-B9B1CAC6-3CB6-49B6-BF27-6181487A8EE6
P2860
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
@en
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
@nl
type
label
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
@en
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
@nl
prefLabel
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
@en
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
@nl
P2093
P50
P1433
P1476
The MET oncogene is a functional marker of a glioblastoma stem cell subtype
@en
P2093
Antonio D'Ambrosio
Bianca Pollo
Francesca De Bacco
Francesca Orzan
Gaetano Finocchiaro
Gigliola Reato
Paola Porrati
Paolo Luraghi
Raffaella Albano
P304
P356
10.1158/0008-5472.CAN-11-3490
P407
P50
P577
2012-06-26T00:00:00Z